Research graph
References from Malignant and stromal partial EMT programmes and cetuximab outcome in head and neck cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41572-020-00224-3
10.1038/s41572-020-00224-3 · External reference
10.14639/0392-100x-suppl.1-40-2020
10.14639/0392-100x-suppl.1-40-2020 · External reference
10.1016/j.critrevonc.2026.105207
10.1016/j.critrevonc.2026.105207 · External reference
10.1016/s0140-6736(19)32591-7
10.1016/s0140-6736(19)32591-7 · External reference
10.1200/jco.2013.53.5633
10.1200/jco.2013.53.5633 · External reference
10.1093/annonc/mdq588
10.1093/annonc/mdq588 · External reference
10.1016/s0140-6736(18)32779-x
10.1016/s0140-6736(18)32779-x · External reference
10.1016/s0140-6736(18)32752-1
10.1016/s0140-6736(18)32752-1 · External reference
10.1200/jco.2006.06.7447
10.1200/jco.2006.06.7447 · External reference
Amivantamab in recurrent/metastatic head and neck squamous cell cancer after checkpoint inhibitor and chemotherapy: pivotal results from the phase Ib/II OrigAMI-4 study
10.1200/jco-26-01042 · 2026 · External reference
10.1002/1878-0261.12093
10.1002/1878-0261.12093 · External reference
10.15252/emmm.201404208
10.15252/emmm.201404208 · External reference
10.1016/j.pharmthera.2018.09.007
10.1016/j.pharmthera.2018.09.007 · External reference
10.7554/elife.90298
10.7554/elife.90298 · External reference
10.1016/j.cell.2017.10.044
10.1016/j.cell.2017.10.044 · External reference
10.3389/fbioe.2020.00220
10.3389/fbioe.2020.00220 · External reference
10.1158/1078-0432.ccr-12-1558
10.1158/1078-0432.ccr-12-1558 · External reference
10.1158/0008-5472.can-16-3521
10.1158/0008-5472.can-16-3521 · External reference
Prognostic value of partial EMT-related genes in head and neck squamous cell carcinoma by a bioinformatic analysis
10.1111/odi.13351 · 2020 · External reference
10.1002/1878-0261.13075
10.1002/1878-0261.13075 · External reference
10.1016/j.oraloncology.2019.104458
10.1016/j.oraloncology.2019.104458 · External reference
10.1038/s41467-021-22800-1
10.1038/s41467-021-22800-1 · External reference
Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment
10.1038/s41598-023-28480-9 · 2023 · External reference
10.1002/ijc.33192
10.1002/ijc.33192 · External reference
10.1038/s41467-023-36691-x
10.1038/s41467-023-36691-x · External reference
10.1038/s41586-023-06130-4
10.1038/s41586-023-06130-4 · External reference
Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transition
10.1038/s41588-026-02723-7 · 2026 · External reference
10.3389/fonc.2023.1249895
10.3389/fonc.2023.1249895 · External reference
10.1016/j.isci.2024.110116
10.1016/j.isci.2024.110116 · External reference
Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat
2022 · External reference
10.1186/s12943-022-01646-1
10.1186/s12943-022-01646-1 · External reference
10.1186/s12943-025-02290-1
10.1186/s12943-025-02290-1 · External reference
10.1186/s13073-026-01612-2
10.1186/s13073-026-01612-2 · External reference
10.1038/nature14129
10.1038/nature14129 · External reference
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer
10.1002/ijc.30808 · 2017 · External reference
10.1371/journal.pone.0056823
10.1371/journal.pone.0056823 · External reference
10.1158/1078-0432.ccr-15-2547
10.1158/1078-0432.ccr-15-2547 · External reference
10.1172/jci.insight.151982
10.1172/jci.insight.151982 · External reference
10.1016/j.cell.2016.06.017
10.1016/j.cell.2016.06.017 · External reference
10.1038/s41586-019-1186-3
10.1038/s41586-019-1186-3 · External reference
10.1016/j.ccell.2020.12.007
10.1016/j.ccell.2020.12.007 · External reference
10.1158/1078-0432.ccr-12-2647
10.1158/1078-0432.ccr-12-2647 · External reference
10.1002/ijc.29649
10.1002/ijc.29649 · External reference
10.18632/oncotarget.24416
10.18632/oncotarget.24416 · External reference
10.1158/1078-0432.ccr-16-1469
10.1158/1078-0432.ccr-16-1469 · External reference
10.1093/nar/gkac959
10.1093/nar/gkac959 · External reference
10.1016/j.oraloncology.2021.105348
10.1016/j.oraloncology.2021.105348 · External reference
10.1038/s41422-020-0374-x
10.1038/s41422-020-0374-x · External reference
10.1038/s41467-021-21043-4
10.1038/s41467-021-21043-4 · External reference
10.1038/s41587-020-00795-2
10.1038/s41587-020-00795-2 · External reference
10.1186/1471-2105-9-559
10.1186/1471-2105-9-559 · External reference
The Molecular Signatures Database (MSigDB) hallmark gene set collection
10.1016/j.cels.2015.12.004 · 2015 · External reference
10.1093/biomet/80.1.27
10.1093/biomet/80.1.27 · External reference
10.1002/sim.1047
10.1002/sim.1047 · External reference
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
10.18632/oncotarget.27763 · 2020 · External reference
10.1038/s41467-022-30755-0
10.1038/s41467-022-30755-0 · External reference
10.1038/s41556-024-01469-w
10.1038/s41556-024-01469-w · External reference
10.1016/0197-2456(86)90046-2
10.1016/0197-2456(86)90046-2 · External reference
10.1002/sim.791
10.1002/sim.791 · External reference
10.1093/nar/gkac328
10.1093/nar/gkac328 · External reference
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat
2020 · External reference
10.1186/s13059-021-02540-7
10.1186/s13059-021-02540-7 · External reference
10.1093/nar/gkad976
10.1093/nar/gkad976 · External reference
10.1093/nar/gkv1277
10.1093/nar/gkv1277 · External reference
10.1093/nar/gky1131
10.1093/nar/gky1131 · External reference
10.1093/nar/gkaa1074
10.1093/nar/gkaa1074 · External reference
10.1038/ncomms10331
10.1038/ncomms10331 · External reference
10.1186/s13059-017-1382-0
10.1186/s13059-017-1382-0 · External reference
10.2307/2346101
10.2307/2346101 · External reference
10.5281/zenodo.23065628
10.5281/zenodo.23065628 · External reference